Live Chat

Gilead लाइव चार्ट

उपकरण मूल बातें

Weekly Search
Weekly
Daily
दिनांक बंद करें परिवर्तन (%) परिवर्तित करें खुला उच्च कम

जानकारी

स्प्रेड

0.57

स्प्रेड (%)

0.6213 %

लीवरेज

1:10

ओवरनाइट ब्याज विक्रय

-0.0597 %

overnight_interest_sell

-0.0292 %

मुद्रा

USD

ट्रेडिंग घंटे

बाज़ार बंद है

शुक्रवार

14:31 - 20:59

सोमवार

14:31-20:59

मंगवार

14:31-20:59

बुधवार

14:31-20:59

गुरुवार

14:31-20:59

विश्लेषण और सांख्यिकी

खुला

---

पिछला बंद

---

52 सप्ताह उच्च/निम्न्च

--- – ---

बाज़ार आकार

117585453056

बकाया शेयर

1246000000

प्राप्ति की तिथि (आगे)

2013-01-28

लाभांश आय 

2024-09-27

पूर्व-लाभांश तिथि

2024-12-13

अग्रिम वार्षिक लाभांश दर 

3.08

अग्रिम वार्षिक लाभांश आय

0.0326

EPS

0.09

इस उपकरण के बारे में अधिक जानें

Gilead Gilead Sciences Inc
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, Sunlencs, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, for the treatment of COVID-19; and Epclusa, Harvoni, Vemlidy, and Viread for the treatment of viral hepatitis. It also offers Yescarta, Tecartus, and Trodelvy products for the treatment of oncology; Letairis, an oral formulation for the treatment of pulmonary arterial hypertension; and AmBisome, a liposomal formulation for the treatment of serious invasive fungal infections. The company has collaboration agreements with Arcus Biosciences, Inc.; Merck Sharp & Dohme Corp.; Pionyr Immunotherapeutics Inc.; Tizona Therapeutics, Inc.; Galapagos NV; Janssen Sciences Ireland Unlimited Company; Japan Tobacco, Inc.; Dragonfly Therapeutics, Inc.; Arcellx, Inc.; Everest Medicines; Merck & Co, Inc.; Tentarix Biotherapeutics Inc.; Marengo Therapeutics; and Assembly Biosciences, Inc. It also has research collaboration, option, and license agreement with Merus N.V. for the discovery of novel dual tumor-associated antigens (TAA) targeting trispecific antibodies. The company was incorporated in 1987 and is headquartered in Foster City, California.

संबंधित उपकरण

संपत्ति
बेचें
खरीदें
(%) परिवर्तित करें
view_all_instruments

नवीनतम समाचार

दुनिया भर की लेटेस्ट फ़ाइनेंशियल न्यूज़ से अपडेटेड रहें।

गुरुवार, 14 नवंबर 2024

Dogecoin surges after Elon Musk issues crypto endorsement

Nvidia Blackwell AI Chips

गुरुवार, 14 नवंबर 2024

Week ahead: Tech rally hinges on Nvidia earnings

Dogecoin surges

बुधवार, 13 नवंबर 2024

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

बुधवार, 13 नवंबर 2024

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

बुधवार, 13 नवंबर 2024

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points

मंगवार, 12 नवंबर 2024

UK stock market news: Helium One share price trading 16.1% higher

मंगवार, 12 नवंबर 2024

Leveraged ETF to package Warren Buffett's Berkshire Hathaway B stock

मंगवार, 12 नवंबर 2024

Dogecoin surges 20% after Department of Government Efficiency announcement

Trustpilot
Live Chat